Esophagus and Gastrointestinal Junction Tumors.
Adenocarcinoma
/ pathology
Barrett Esophagus
/ complications
Carcinoma, Squamous Cell
/ pathology
Combined Modality Therapy
Disease Progression
Early Detection of Cancer
Esophageal Neoplasms
/ pathology
Esophagectomy
/ methods
Esophagogastric Junction
/ pathology
Esophagoscopy
/ methods
Female
Gastroesophageal Reflux
/ complications
Humans
Male
Minimally Invasive Surgical Procedures
/ methods
Neoplasm Grading
Neoplasm Staging
Prognosis
Risk Factors
Esophageal adenocarcinoma
Esophageal cancer
Esophageal squamous cell carcinoma
Gastroesophageal junction cancer
Journal
The Surgical clinics of North America
ISSN: 1558-3171
Titre abrégé: Surg Clin North Am
Pays: United States
ID NLM: 0074243
Informations de publication
Date de publication:
Jun 2020
Jun 2020
Historique:
entrez:
14
5
2020
pubmed:
14
5
2020
medline:
10
6
2020
Statut:
ppublish
Résumé
Esophageal squamous cell carcinoma and adenocarcinoma account for 95% of all esophageal malignancies. The rates of esophageal adenocarcinoma have increased in Western countries, making it the predominant type of esophageal cancer. Treatment of both types of cancer has transformed to a more minimally invasive approach, with endoscopic methods being used for superficial cancers and more frequent use of video-assisted and laparoscopic modalities for locally advanced tumors. The current National Comprehensive Cancer Network guidelines advocate a trimodal approach to treatment, with neoadjuvant chemoradiation and surgery for locally advanced cancers.
Identifiants
pubmed: 32402297
pii: S0039-6109(20)30016-5
doi: 10.1016/j.suc.2020.02.003
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
507-521Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Disclosure The authors have nothing to disclose.